| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/04/2007 | WO2007002093A2 Ansamycin formulations and methods of use thereof |
| 01/04/2007 | WO2007002088A2 Psat1s as modifiers of the pten/akt pathway and methods of use |
| 01/04/2007 | WO2007002087A2 Cdc6s as modifiers of the pten/akt pathway and methods of use |
| 01/04/2007 | WO2007002081A2 Gfats as modifiers of the axin pathway and methods of use |
| 01/04/2007 | WO2007002080A2 Eya2s as modifiers of the pten/akt pathway and methods of use |
| 01/04/2007 | WO2007001399A2 Compositions, splice variants and methods relating to cancer specific genes and proteins |
| 01/04/2007 | WO2007001335A2 Ramoplanin derivatives possessing antibacterial activity |
| 01/04/2007 | WO2007001332A2 Anti-pathogen immunoadhesins |
| 01/04/2007 | WO2007001094A1 Artificial lung surfactant composition |
| 01/04/2007 | WO2007001010A1 Pharmaceutical for treatment of parkinson’s disease |
| 01/04/2007 | WO2007001006A1 Agent for ameliorating heavy metal-induced disorders, and medicinal composition, food and cosmetic containing the same |
| 01/04/2007 | WO2007000924A1 Pharmaceutical composition comprising substance capable of inhibiting or promoting progranulin activity and screening method for substance capable of inhibiting or promoting progranulin activity |
| 01/04/2007 | WO2007000884A1 Prophylactic/therapeutic agent for bone/joint disease and screening method for the agent |
| 01/04/2007 | WO2007000770A2 Protein kinase c inhibitors for prevention of insulin resistance and type 2 diabetes |
| 01/04/2007 | WO2007000769A2 RECOMBINANT INTERFERON α2 (IFNα2) MUTANTS |
| 01/04/2007 | WO2007000619A1 Use of a mixture of superoxide dismutase and catalase for treating inflammatory skin lesions |
| 01/04/2007 | WO2007000584A1 Treatment of fungal and/or protist infections |
| 01/04/2007 | WO2007000320A2 Method for diagnosing rheumatic diseases |
| 01/04/2007 | WO2007000118A1 Exendin 4 polypeptide fragments and use thereof |
| 01/04/2007 | WO2007000036A2 Use of mas g-protein-coupled receptor agonists and antagonists as apoptotic activity modulators for prevention and treatment of diseases |
| 01/04/2007 | WO2006106521A3 Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules |
| 01/04/2007 | WO2006096173A8 Pharmaceutical compositions and methods for peptide treatment |
| 01/04/2007 | WO2006083792A3 Novel polypeptide ligands for toll-like receptor 2 (tlr2) |
| 01/04/2007 | WO2006068480A3 Protein hydrolysate enriched in peptides inhibiting dpp-iv and their use |
| 01/04/2007 | WO2006067198A3 Targeted use of engineered enzymes |
| 01/04/2007 | WO2006063329A3 Enhanced protection against mycobacterium tuberculosis |
| 01/04/2007 | WO2006062973A3 Use of organic compounds |
| 01/04/2007 | WO2006050172A3 Combination cancer immunotherapy with co-stimulatory molecules |
| 01/04/2007 | WO2006023782A3 Refolding transforming growth factor beta family proteins |
| 01/04/2007 | WO2006023586A3 Guanylhydrazone compounds, compositions, methods of making and using |
| 01/04/2007 | WO2006019982A3 Pin1-modulating compounds and methods of use thereof |
| 01/04/2007 | WO2006017853A3 Mutant interleukin-15-containing compositions and suppression of an immune response |
| 01/04/2007 | WO2006017824A3 Igf-bp3-related methods for inhibiting tumor growth |
| 01/04/2007 | WO2005074546A3 Modified human growth hormone polypeptides and their uses |
| 01/04/2007 | US20070004906 Monocyte chemoattractant protein(MCP), mutants whose mucopolysaccharide binding site is eliminated by replacements, used to inhibit the migration and activation of leukocytes expressing their receptors; prevention of cancer, inflammatory, autoimmune and vascular diseases |
| 01/04/2007 | US20070004904 G-csf conjugates |
| 01/04/2007 | US20070004744 Prophylaxis and/or treatment of portal hypertension |
| 01/04/2007 | US20070004669 Mono-, di- or trifluoromethyl derivatives, e.g., 6-amino-9-(2-C-fluoromethyl- beta -D-ribofuranosyl)purine, 2'-C-(fluoromethyl)-5-methylcytidine and 2-amino-9-(2-C-fluoromethyl- beta -D-ribofuranosyl)-3,9-dihydropurin-6-thione; used to treat a hepatitis C virus infection |
| 01/04/2007 | US20070004668 Antisense permeation enhancers |
| 01/04/2007 | US20070004667 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 01/04/2007 | US20070004666 Methods for modulating apoptotic cell death |
| 01/04/2007 | US20070004665 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 01/04/2007 | US20070004664 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 01/04/2007 | US20070004663 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 01/04/2007 | US20070004659 Method for preventing or delaying the onset of diabetes |
| 01/04/2007 | US20070004658 Method and means for treatment of osteoarthritis |
| 01/04/2007 | US20070004655 Nr-cam gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors |
| 01/04/2007 | US20070004646 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 01/04/2007 | US20070004645 Aromatic amides as potentiators of bioefficacy of anti-infective drugs |
| 01/04/2007 | US20070004644 For oral administration; atherosclerosis; cardiovascular diseases |
| 01/04/2007 | US20070004643 ((1S)-1-((((1S)-1-benzyl-2,3-dioxo-3-(cyclopropylamino)propyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester; ischemic disease, immunologic disease, multiple sclerosis, Alzheimer's disease, osteoporosis, diseases caused by brain tissue damage, cataract, glaucoma |
| 01/04/2007 | US20070004642 Oxadiazole derivatives and drugs containing these derivatives as the active ingredient |
| 01/04/2007 | US20070004641 Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamate |
| 01/04/2007 | US20070004640 Treatment of dry eye |
| 01/04/2007 | US20070004639 Methods and compositions for treating Parkinson's disease |
| 01/04/2007 | US20070004638 form C dihydrates; useful as they act directly on the pituitary gland cells to release growth hormone; storage stability |
| 01/04/2007 | US20070004637 Alzheimer's disease; for promoting secretion of amyloid precursor protein-alpha (sAPP), neurodegenerative disease, neuropathy in cerebrovascular disease, head trauma, spinal damage, encephalitis sequela, or cerebral palsy, memory disorder |
| 01/04/2007 | US20070004636 Method of degrading transcriptional factors of saccharometabolism-associated gene, method for inhibiting the degradation, and agent for inhibiting degradation and degradation inhibitor |
| 01/04/2007 | US20070004635 Method of treating interferon non-responders using HCV protease inhibitor |
| 01/04/2007 | US20070004634 Insulin and IGF-1 receptor agonists and antagonists |
| 01/04/2007 | US20070004633 Administering a peptide containing Gly-His-Lys conjugated to an alkanoic acid, lipoic acid or its reduced form, dihydrolipoic acid, N-lipoyllysine or retinoic acid to stimulate hair growth or stop hair loss; may be mixed with a sunscreen |
| 01/04/2007 | US20070004632 An isolated BAX gene frameshift-mutation polypeptide is used to stimulate the proliferation of human T cells, T cellular immunity; for treating cancer patient; cancer vaccines |
| 01/04/2007 | US20070004631 Method for synthesis of phospholipids-PEG-biomolecule conjugates |
| 01/04/2007 | US20070004630 Treating cell proliferation disease; aberrant fetoplacental growth; cancer |
| 01/04/2007 | US20070004629 K9 and equine joint health food supplement and method of administering |
| 01/04/2007 | US20070004628 Compositions and methods for nerve regeneration |
| 01/04/2007 | US20070004627 Compounds and methods for treatment of cancer |
| 01/04/2007 | US20070004626 treating osteoporosis caused by imbalance of osteoclast and osteoblast activity, glandular disorders with a Syk kinase inhibitor a 2,4-pyrimidinediamine compound; alendronate, calcitonin, estrogen and selective estrogen receptor modulators; side effect reduction |
| 01/04/2007 | US20070004625 Use of complement inhibitory proteins to treat spinal cord injury |
| 01/04/2007 | US20070004624 Methods for modulating bone tissue formation, orthogenic agents and pharmaceutical compositions |
| 01/04/2007 | US20070004623 Use of hydroxylated amino acids for treating diabetes |
| 01/04/2007 | US20070004622 Imidazole derivative, process for producing the same, and use |
| 01/04/2007 | US20070004621 Bex4 nucleic acids, polypeptides, and method of using |
| 01/04/2007 | US20070004620 Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus |
| 01/04/2007 | US20070004619 Relaxin superfamily peptide analogues |
| 01/04/2007 | US20070004618 Competitive Regulation of Hepcidin mRNA by Soluble and Cell-Associated Hemojuvelin |
| 01/04/2007 | US20070004617 Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments |
| 01/04/2007 | US20070004616 Glucagon-like peptide-1 (GLP-1); for treatment of diabetes, obesity, excessive appetite, insufficient satiety, and metabolic disorders; for converting liver stem/progenitor cells into functional pancreatic cells |
| 01/04/2007 | US20070004039 Immortalized hepatocytes |
| 01/04/2007 | US20070004012 Reacting chondroitin disaccharide with a recombinantly produced 2-O sulfatase; using 2-O sulfatase for degrading and analyzing glycosaminoglycans (GAGs) present in a sample |
| 01/04/2007 | US20070004009 Methods for making recombinant proteins using apoptosis inhibitors |
| 01/04/2007 | US20070004008 Human ccv polypeptides |
| 01/04/2007 | US20070004007 Peptide consisting tumor necrosis factor alpha converting enzyme protease inhibitor; growth hormone related disease; Alzheimer's disease; used to induce apoptosis of cancer cells |
| 01/04/2007 | US20070004005 Tendon-inducing compositions |
| 01/04/2007 | US20070003986 Methods for identifying compounds for treating diabetes mellitus |
| 01/04/2007 | US20070003963 RNA sequence-specific mediators of RNA interference |
| 01/04/2007 | US20070003962 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response |
| 01/04/2007 | US20070003961 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response |
| 01/04/2007 | US20070003960 Producing knockdown cells; Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response |
| 01/04/2007 | US20070003928 Novel use of edg receptors |
| 01/04/2007 | US20070003926 Nucleic acid sequences from drosophila melanogaster that encode proteins essential for viability and uses thereof |
| 01/04/2007 | US20070003630 Anti-angiogenic compositions and methods of use |
| 01/04/2007 | US20070003629 Anticancer agents; prevent forming blood vessels; removal blockage |
| 01/04/2007 | US20070003598 Osteogenic implants for soft tissue |
| 01/04/2007 | US20070003593 Bone paste |
| 01/04/2007 | US20070003578 Chimeric protein comprising non-toxic pseudomonas exotoxin and type IV pilin sequences |
| 01/04/2007 | US20070003574 antibody or antiserum directed against a structural protein of Ljungan picornavirus; cardiovascular, nervous system and metabolic disorders; Myocarditis, Cardiomyopathia, Guillain Barre Syndrome, and Diabetes Mellitus, Multiple Sclerosis, Chronic Fatigue Syndrome, Myasthenia Gravis |
| 01/04/2007 | US20070003573 Viral expression vector for use in the treatment and diagnosis of viral, cardiovascular, nervous system and metabolic disorders |
| 01/04/2007 | US20070003571 Modified herpes simplex viral particle for targeting and destroying tumor cells |
| 01/04/2007 | US20070003568 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |